Session 2: Maximizing the survival benefit through a sequential treatment strategy in locally advanced or metastatic urothelial cancer

More details

Join the ACE Oncology Network Today!

Discover the latest updates in oncology, and engage with experts in the field.

JOIN ACE ONCOLOGY NOW

Upcoming Events

See All Upcoming Events
Urothelial Cancer Preceptorship

Urothelial Cancer Preceptorship

The therapeutic landscape for urothelial cancer has undergone significant transformation...

Online Education

See All Online Education

CME

article-thumbnail

Session 2: Maximizing the survival benefit through a sequential treatment strategy in locally advanced or metastatic urothelial cancer

3 videos / 2 slide decks

CME

article-thumbnail

Session 1: Reconsidering the optimization of first-line treatment strategies in locally advanced or metastatic urothelial cancer

3 videos / 2 slide decks

CME

article-thumbnail

Clinical Insights on the Treatment Algorithm in Unresectable Locally Advanced or Metastatic Urothelial Cancer

4 videos / 4 slide decks
article-thumbnail

Navigating Treatment Decisions in Advanced NSCLC:
Update on Molecular Testing and New Targeted Treatment Options

7 videos / 4 slide decks

Latest Blogs

See Latest Blogs
Highlights from the WCLC 2023 – Targeting MET Alterations

Highlights from the WCLC 2023 – Targeting MET Alterations

The 2023 World Conference on Lung Cancer (WCLC 2023) was held...
FDA Approved 6 New Oncology Indications in August 2023

FDA Approved 6 New Oncology Indications in August 2023

The US FDA approved six new indications for cancer management...
FDA Approved 6 New Oncology Indications in May-July 2023

FDA Approved 6 New Oncology Indications in May-July 2023

The US FDA approved six new indications for cancer management...
FDA Approved Six New Oncology Indications in March-April 2023

FDA Approved Six New Oncology Indications in March-April 2023

The US FDA approved six new indications for cancer management...